Global X China Biotech ETF (02820.HK) Rises 7.54% in Afternoon Trade, AUM at HKD 557 Million
NewTimeSpace News: As of 13:28 on June 29, Global X China Biotech ETF (02820.HK) gained 7.54%, trading at HKD 63.880. The ETF recorded a high of HKD 64.640 and a low of HKD 59.800, representing an intraday amplitude of 8.15%, with a volume of 51,700 shares and a turnover of HKD 3.2738 Million, at an average price of HKD 63.384. The current Net Asset Value (NAV) stands at HKD 60.537, with total issued shares of 9.20 Million and Assets Under Management (AUM) of HKD 557 Million.
Global X China Biotech ETF (02820.HK) tracks the Solactive China Biotech Index NTR (Net Total Return). The constituent stocks of the index are highly concentrated in leading enterprises and boast distinctive innovative characteristics.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Global X China Biotech ETF(02820.HK) Rises 0.92% Intraday, Average Traded Price at HK$59.377
- Global X China Biotech ETF (02820.HK) Rises 2.55% in Afternoon Trading as Drug Price Governance Officially Enters New Phase
- GEMILANG INTL(06163.HK)FY 25/26 Interim Report - Profit Attributable to Shareholders stood at USD 9 thousand, YoY decrease of 67.86%